Editorial

TOWARDS COMPUTER AIDED DESIGN (CAD) OF USEFUL MICROORGANISMS
Utilizing microorganisms in industrial processes is one of the most important achievements in the 21st century. Conventional industrial processes usually require energy-consuming conditions such as high temperature and high pressure, and often use hard-to-recycle chemical resources, resulting in harmful impact on the environment such as exhaustion of natural resources and accumulation of industrial waste. Replacing these processes with biology-based technologies could drastically reduce cost, energy, and the destruction of the environment.
At present, microorganisms used in bioprocessesing are selected from the existing pool in nature. Research has shown that many of the genes of these microorganisms are unnecessary for application in industrial environments, which, as opposed to the natural environment, are well controlled and constant. For industrial applications, such genes are not only redundant but also often obstructive when expressed, because they waste energy and sometimes even hinder the objective. Trimming microorganisms genetically to optimize their productivity is therefore a key technology of immense industrial importance. For this new type of simulation-oriented biology, Keio University opened the Institute for Advanced Biosciences (IAB) in Tsuruoka (a northern city of Japan), based on a large donation of more than 12 billion JYEN (equivalent to approx. 100 million US dollars) by the local government (http://www.ttck.keio.ac.jp). The institute consists of research units devoted towards bioinformatics, metabolic engineering, analytical chemistry, and genome engineering. The ultimate goal of this international research institute is to construct whole cell models in silico based on data generated by high-throughput metabolome analyses, providing raw material for designing a novel genome. The entire data would be fed into E-CELL for computer simulation, enabling creation of novel real cells by genome engineering. Such cells could then be custom-made for specific scientific and industrial applications.
TRENDS IN JAPAN
To achieve this highly complex and coordinated task of creating useful microorganisms through CAD (computer aided design), many different technologies must be combined together. These include:
(1) Enzyme engineering: to refine enzymes and to analyse kinetic parameters in vitro.
(2) Metabolic engineering: to analyse flux rates in vivo.
(3) Analytical chemistry: to determine and analyse the quantity of metabolites efficiently.
(4) Genetic engineering: to cut-and-paste genes on demand, for modifying metabolic pathways.
(5) Simulation science: to efficiently and accurately simulate a large number of reactions.
(6) Knowledge engineering: to construct, edit, and maintain large metabolic knowledge bases.
(7) Mathematical engineering: to estimate and tune unknown parameters.
WHOLE CELL SIMULATION
Computer modeling and simulation is an essential part of this new technology. A major challenge is to construct a computer model of the whole microbial cell. The E-CELL Project (http://www.e-cell.org) was launched in 1996 at Keio University to model and simulate various cellular processes with the ultimate goal of simulating the cell as a whole. In 1997, we successfully constructed a virtual cell with 127 genes sufficient for 'self-support'. The gene set was selected from the genome of Mycoplasma genitalium. Processes included transcription, translation, membrane transport, the glycolysis pathway for energy production and the phospholipid biosynthesis pathway for membrane structure. Since the entire repertoire of protein and membrane structure was modeled to degrade spontaneously over time, this virtual cell was programmed to synchronize the synthesis of proteins and phospholipid bilayer in order to survive. The cell uptakes glucose as its energy source, from the culture medium, and depletion of glucose in the environment therefore results in 'cell death from hunger'. Such cells with 127 genes do not, of course, exist in nature. The version 1.0 of this virtual cell was created to provide proof-of-the-concept of whole cell modeling, never attempted before. It was based on a fictitious cell model with assumed parameter values, and some may say that it is nothing more than a toy in a biological sense. This 'toy' model nevertheless consists of 495 reactions and 4268 molecular species! The successful completion of this sophisticated model has provided the evidence for the first time that whole cell modeling may not be an impossible task in the foreseeable future.
QUANTITATIVE SIMULATION
Although the scientific community is still many years away from constructing accurate and more realistic models of the whole cell, various cellular processes have nevertheless been modeled by many different research groups. Our E-CELL project team, among others, has been working on bacterial chemotaxis, circadian rhythms, photosynthesis, cell cycle and cell division. For modeling and simulating gene expression, we are working on general quantitative models and their application to gene regulation network, especially E.coli lactose operon and lambda phage genetic switch. For organelles, a quantitative model of mitochondria is nearly complete. For human cells, we have already developed a quantitative model of erythrocytes, and is currently being used in modeling and simulating enzyme deficiencies causing anemia. Other human cells in the E-CELL system pipeline are myocardial cells, neural cells, and pancreatic beta-cells.
One of the major problems in constructing largescale cell models is lack of quantitative data. Most of the biological knowledge available in the literature is qualitative, e.g. gene function, pathway maps, proteinprotein interaction, etc. For simulation, quantitative data such as concentrations of metabolites and enzymes, flux rates, kinetic parameters and dissociation constants are needed. The limited availability of precise quantitative data from the published literature makes metabolome projects indispensable for cell modeling, for it enables measurement of various components systematically and accurately.
METABOLOME RESEARCH
The Metabolome group of our institute is developing methodologies for mass-production of quantitative metabolic data. We analyse metabolic flux distributions (MFDs) in varying conditions of dissolved oxygen (DO) concentration, pH, temperature, and medium composition. We also label certain substrates with U-13 C or 1-13 C, and measure isotope distribution of intercellular metabolites.
A major challenge is to develop high-throughput technologies for measurement of intra-cellular metabolites. We are developing novel methods for the quantitative comprehensive analysis of metabolites using capillary electrophoresis coupled to mass spectrometry (CE-MS). More than 30 positively charged metabolites including amino acids and amines have been roughly separated by CE and selectively detected by MS. Additionally, many negatively charged metabolites such as organic acids have been simultaneously analysed in other conditions. Our method is simple, rapid, and sensitive and can be readily applied to the real samples. In the future, we extend this method to enable us to measure hundreds of metabolites at once.
Thus, it is possible to collect large amounts of data for a variety of cell states to construct quantitative models. These models can be refined iteratively until simulation results match a given set of data.
EPILOGUE
For long, bioinformatics has played a role of technical infrastructure for research in experimental biology. Now the time has come for a 'paradigm shift' to look the other way around. Many bioinformatics projects, such as computer modeling and simulation of cellular processes, recently need a large amount of biological data, and thus well-designed, systematic experimentation is becoming an important infrastructure for those bioinformatics projects. Perhaps, these days it makes little sense to make a distinction between bioinformaticians and experimental biologists. After all, biology cannot stand without informatics, and bioinformatics itself is, in my view, a new type of biology.
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